Neil L. Berinstein

University of Toronto, Toronto, ON, Canada 
Immunology, Molecular Biology
"Neil Berinstein"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Da Silva DM, Woodham AW, Naylor PH, et al. (2015) Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research
Levy R, Ganjoo KN, Leonard JP, et al. (2014) Active idiotypic vaccination versus control immunotherapy for follicular lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1797-803
Guirguis HR, Cheung MC, Piliotis E, et al. (2014) Survival of patients with transformed lymphoma in the rituximab era. Annals of Hematology. 93: 1007-14
Berinstein NL, Karkada M, Morse MA, et al. (2012) First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine. 10: 156
Bos R, van Duikeren S, van Hall T, et al. (2007) Characterization of antigen-specific immune responses induced by canarypox virus vaccines. Journal of Immunology (Baltimore, Md. : 1950). 179: 6115-22
Pennell N, Woods A, Reis M, et al. (2006) Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction. The Journal of Molecular Diagnostics : Jmd. 8: 40-50
Tomlin JL, Guinn BA, Penn LZ, et al. (2005) Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity. Leukemia & Lymphoma. 46: 581-92
Gitelson E, Hammond C, Mena J, et al. (2003) Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 1656-65
Mangel J, Buckstein R, Imrie K, et al. (2002) Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Seminars in Oncology. 29: 56-69
Gitelson E, Spaner D, Buckstein R, et al. (2002) T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin. British Journal of Haematology. 116: 122-7
See more...